Get the Stockscreener App
327.38
0.91%
2.96
After Hours:
328.50
1.12
+0.34%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $327.38, with a volume of 12.56M.
It is up +0.91% in the last 24 hours and down -4.39% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$324.42
Open:
$325.56
24h Volume:
12.56M
Relative Volume:
4.40
Market Cap:
$176.29B
Revenue:
$35.89B
Net Income/Loss:
$7.01B
P/E Ratio:
25.31
EPS:
12.9352
Net Cash Flow:
$11.54B
1W Performance:
+3.03%
1M Performance:
-4.39%
6M Performance:
+13.03%
1Y Performance:
+25.34%
1-Day Range:
$324.73
$331.50
1-Week Range:
$319.06
$332.80
52-Week Range:
$257.05
$346.38
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
327.38 | 174.69B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,071.44 | 945.93B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
206.37 | 501.88B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
226.82 | 393.81B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
136.06 | 259.56B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
101.09 | 249.91B | 63.90B | 19.05B | 13.05B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-25 | Upgrade | Erste Group | Hold → Buy |
| Nov-24-25 | Resumed | Truist | Hold |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Sep-03-25 | Resumed | Raymond James | Mkt Perform |
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts - ts2.tech
Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN - MarketBeat
Bartlett & CO. Wealth Management LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Has Amgen’s 26% Rally in 2025 Already Priced In Its Obesity and Oncology Ambitions? - Yahoo Finance
Is Amgen Inc. stock a top momentum playWeekly Stock Summary & Daily Stock Trend Watchlist - ulpravda.ru
Amgen to Cut US Drug Prices, Expand Patient Access - marketscreener.com
Amgen takes action with U.S. government to lower medicine costs By Investing.com - ca.investing.com
Amgen says Aimovig & Amjevita to be available at discounted monthly price of $299 under deal with U.S. govt - marketscreener.com
Amgen (AMGN) Moves to Reduce Drug Prices in Collaboration with U - GuruFocus
Amgen Strikes Agreement With US Government to Lower Drug Costs - marketscreener.com
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire
Amgen Advances Olpasiran Heart Plaque Study, Highlighting a Growing Bet on Lipoprotein(a) - TipRanks
Talbot Financial LLC Purchases 5,839 Shares of Amgen Inc. $AMGN - MarketBeat
Bristol Myers, Merck, Amgen among latest to announce U.S. drug pricing deal - Seeking Alpha
Is Amgen Inc. stock trading near support levels2025 Price Momentum & Technical Confirmation Trade Alerts - DonanımHaber
How Amgen Inc. stock reacts to oil pricesJuly 2025 Review & Community Trade Idea Sharing Platform - DonanımHaber
How Amgen Inc. stock performs in weak economy2025 Analyst Calls & Weekly Top Performers Watchlists - Улправда
Chemotherapy Induced Anemia Market Intelligence Report 2025-2032, Featuring Amgen, Johnson & Johnson - PharmiWeb.com
Why Amgen Inc. stock remains on watchlistsJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - Улправда
Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Inductive Bio, Amgen Join ARPA-H’s Push To Replace Animal Tox With AI And Human Tissues - Citeline News & Insights
Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat
2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen
Amgen (AMGN) Valuation Check After FDA Expansion of UPLIZNA in Generalized Myasthenia Gravis - Yahoo Finance
HSBC turns more bullish on Amgen (AMGN) into 2026 - MSN
HSBC Turns More Bullish on Amgen (AMGN) into 2026 - Insider Monkey
Amgen (AMGN) Among Pharma Giants in Drug Pricing Talks - GuruFocus
Thurston Springer Miller Herd & Titak Inc. Reduces Stake in Amgen Inc. $AMGN - MarketBeat
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Amgen stock rating maintained by Oppenheimer with price target of $380 - Investing.com UK
Sanders Morris Harris LLC Takes $1.21 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc - MarketBeat
Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease - Insider Monkey
Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts - ts2.tech
3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most - Investing.com
Aaron Wealth Advisors LLC Has $51.17 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
How Amgen’s New CD19-Targeted gMG Approval At Amgen (AMGN) Has Changed Its Investment Story - Yahoo Finance
What Amgen (AMGN)'s Expanded UPLIZNA Approval in Generalized Myasthenia Gravis Means For Shareholders - simplywall.st
Amgen (AMGN) Rises As Market Takes a Dip: Key Facts - Yahoo Finance Singapore
Goldman Sachs, Amgen share gains lead Dow's 125-point climb - MSN
Amgen sees RS rating improve to 71 - MSN
Valeo Financial Advisors LLC Has $6.47 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lowered by Texas Permanent School Fund Corp - MarketBeat
Stance Capital LLC Acquires Shares of 4,463 Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Corient Private Wealth LLC - MarketBeat
30,728 Shares in Amgen Inc. $AMGN Acquired by Caldwell Trust Co - MarketBeat
B. Riley Wealth Advisors Inc. Invests $1.65 Million in Amgen Inc. $AMGN - MarketBeat
Advisory Services Network LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Sees RS Rating Improve To 71 - Investor's Business Daily
Amgen (NASDAQ:AMGN) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):